AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Small molecule therapeutics for treatment of neuropsychiatric disorders

Summary

Glial cell line-derived neurotropic factor (GDNF) is an essential protein for the growth, development, and plasticity of dopaminergic and motor neurons. Elevated GDNF levels are associated with decreased risk for neuropsychiatric disorders, including addiction and depression. This technology describes a class of organic molecules designed to specifically elevate GDNF levels in the brain. By selectively inducing GDNF, the small molecules identified in this technology can be potentially used as a treatment for alcohol abuse, depression, Parkinson's disease, and other neuropsychiatric disorders.

Technology Benefits

These small molecules specifically induce GDNF production without interfering with other signaling pathways in the brainReduced risk of side effectsPatent Information:Patent Pending (WO/2013/028999)Patent Pending (US 20150056699)Tech Ventures Reference: IR M11-026

Technology Application

Potential treatment for alcohol, drug, and other addictionsPotential treatment for depressionPotential treatment for Parkinson's diseasePotential treatment for neuropathic painResearch tool for studying GDNF expression

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here